Teva Pharmaceutical Industries Ltd. ADR-1.50% $19.99B ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Alina Selyukh is a business correspondent at NPR, where she covers retail, low-wage work, big brands and other aspects of the consumer economy. Her work has been recognized by the Gracie Awards ...

Now, GSK is ready to play catch-up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...

GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines. The University of Oxford and GSK are to work on a vaccine to target cells in the ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

ALINA POLYAKOVA is President and CEO of the Center for European Policy Analysis and Donald Marron Senior Fellow at the Johns Hopkins University’s School of Advanced International Studies. Previously, ...